Paper8690751
Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.
Bar-Eli N and 3 others. J Cancer Res Clin Oncol, 1996. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. Papers, record 8690751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8690751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Burkitt Lymphoma | Major topic |
| Lymphoma, B-Cell | Major topic |
| Newcastle disease virus | Major topic |
| Cell Membrane Permeability | |
| Cell Transformation, Viral | |
| Chromium | |
| Chromium Radioisotopes | |
| Cytotoxicity, Immunologic | |
| DNA, Neoplasm | |
| Humans | |
| Lymphocyte Activation | |
| Lymphocytes | |
| Phytohemagglutinins | |
| Pokeweed Mitogens | |
| Sensitivity and Specificity | |
| Tumor Cells, Cultured |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7954437 | Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954437 | PubMed |
| 2 | 4133080 | Lymphocyte receptors for myxoviruses and paramyxoviruses. | J Immunol | 1974 | https://conductscience.org/library/papers/4133080 | PubMed |
| 3 | 2921273 | Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus. | J Cancer Res Clin Oncol | 1989 | https://conductscience.org/library/papers/2921273 | PubMed |
| 4 | 14147810 | EFFECT OF ACTIVE AND ULTRAVIOLET-IRRADIATED INACTIVE VACCINIA VIRUS ON THE DEVELOPMENT OF SHAY LEUKEMIA IN RATS. | Cancer Res | 1964 | https://conductscience.org/library/papers/14147810 | PubMed |
| 5 | 2462467 | Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2462467 | PubMed |
| 6 | 2474832 | Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2474832 | PubMed |
| 7 | 126271 | Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. | J Exp Med | 1975 | https://conductscience.org/library/papers/126271 | PubMed |
| 8 | 8515058 | Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells. | J Immunol | 1993 | https://conductscience.org/library/papers/8515058 | PubMed |
| 9 | 1744162 | Killing of Burkitt-lymphoma-derived Daudi cells by ultraviolet-inactivated vaccinia virus. | J Cancer Res Clin Oncol | 1991 | https://conductscience.org/library/papers/1744162 | PubMed |
| 10 | 2459402 | Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity. | J Natl Cancer Inst | 1988 | https://conductscience.org/library/papers/2459402 | PubMed |
| 11 | 8275514 | Attenuated veterinary virus vaccine for the treatment of cancer. | Cancer Detect Prev | 1993 | https://conductscience.org/library/papers/8275514 | PubMed |
| 13 | 221925 | Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/221925 | PubMed |
| 14 | 3030235 | Viruses as toxins. With special reference to paramyxoviruses. Brief review. | Arch Virol | 1987 | https://conductscience.org/library/papers/3030235 | PubMed |
| 15 | 4577688 | Participation of lymphocytes in viral infections. | Adv Immunol | 1973 | https://conductscience.org/library/papers/4577688 | PubMed |
| 16 | 2302742 | Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta. | Cell Immunol | 1990 | https://conductscience.org/library/papers/2302742 | PubMed |
| 17 | 2751555 | Elevated virulence of Newcastle disease virus strains following serial passages in kidney cells in vitro. | Avian Dis | 1989 | https://conductscience.org/library/papers/2751555 | PubMed |
| 18 | 2183871 | Tumour necrosis factor: a cytokine with multiple biological activities. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2183871 | PubMed |
| 19 | 2419962 | Arrest of Daudi cell growth by inactive influenza virus in-vitro. | Scan Electron Microsc | 1985 | https://conductscience.org/library/papers/2419962 | PubMed |
| 20 | 838573 | Iodination fo Newcastle disease virus envelope proteins with lactoperoxidase. | Isr J Med Sci | 1977 | https://conductscience.org/library/papers/838573 | PubMed |
| 21 | 4174339 | Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. | Cancer Res | 1968 | https://conductscience.org/library/papers/4174339 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871809 | Therapeutic potential of oncolytic viruses in hematopoietic malignancies: from preclinical insights to clinical realities. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42871809 | PubMed |
| 40567544 | Oncolytic potential of Newcastle Disease Virus in feline lymphoma cells: an in vitro evaluation. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40567544 | PubMed |
| 36217339 | Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases. | Mol Biol | 2022 | https://conductscience.org/library/papers/36217339 | PubMed |
| 34150610 | Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication. | Front Oncol | 2021 | https://conductscience.org/library/papers/34150610 | PubMed |
| 32078405 | Recent advances of oncolytic virus in cancer therapy. | Hum Vaccin Immunother | 2020 | https://conductscience.org/library/papers/32078405 | PubMed |
| 29949934 | Fusogenic Viruses in Oncolytic Immunotherapy. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29949934 | PubMed |
| 27579294 | Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy. | Oncolytic Virother | 2016 | https://conductscience.org/library/papers/27579294 | PubMed |
| 27512670 | Therapeutic potential of oncolytic Newcastle disease virus: a critical review. | Oncolytic Virother | 2015 | https://conductscience.org/library/papers/27512670 | PubMed |
| 26703717 | Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma. | Viruses | 2015 | https://conductscience.org/library/papers/26703717 | PubMed |
| 26640815 | Oncolysis by paramyxoviruses: preclinical and clinical studies. | Mol Ther Oncolytics | 2015 | https://conductscience.org/library/papers/26640815 | PubMed |
| 22393889 | Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. | Future Microbiol | 2012 | https://conductscience.org/library/papers/22393889 | PubMed |
| 21740354 | Bugs and drugs: oncolytic virotherapy in combination with chemotherapy. | Curr Pharm Biotechnol | 2012 | https://conductscience.org/library/papers/21740354 | PubMed |
| 20237963 | Cancer stem cells: the final frontier for glioma virotherapy. | Stem Cell Rev Rep | 2011 | https://conductscience.org/library/papers/20237963 | PubMed |
| 19643532 | Virotherapy against malignant glioma stem cells. | Cancer Lett | 2010 | https://conductscience.org/library/papers/19643532 | PubMed |
| 18535620 | Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. | Cancer Gene Ther | 2008 | https://conductscience.org/library/papers/18535620 | PubMed |
| 10759404 | Oncolytic viruses. | Invest New Drugs | 1999 | https://conductscience.org/library/papers/10759404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8690751
GET https://conductscience.org/api/papers/v1/8690751/references?page=2